Banxiaxiexin Decoction Combined With Vonoprazan-Amoxicillin Dual Therapy in H.Pylori Eradication
Status:
NOT_YET_RECRUITING
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
Vonoprazan and high-dose amoxicillin dual therapy was used as a control group to evaluate the clinical effiency and safety of Banxiaxiexin decoction combined with vonoprazan and high-dose amoxicillin dual therapy in the treatment of helicobacter pylori infection complicated with functional dyspepsia,through a randomized controlled trail.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Nanjing First Hospital, Nanjing Medical University